Rare diseases
Investigational molecules
Locations
359 conditions with trials, the busiest first
849 trials across Europe, recruiting first
Study of Topical Donepezil Hydrochloride Cream for Safety and Effectiveness in Adult Patients with Acne Vulgaris
DenmarkStudy of Acasunlimab Alone and Combined With Pembrolizumab in Patients With Advanced Skin Melanoma That Returned or Did Not Respond to Prior Treatment
FranceStudy of Rocatinlimab with Topical Treatments for Adults with Moderate to Severe Atopic Dermatitis
AustriaEvaluation of CIT-013 at two dose levels compared to placebo for treating moderate to severe Hidradenitis Suppurativa
GermanyStudy of ritlecitinib for treating severe alopecia areata in children aged 6 to under 12 years
CzechiaStudy comparing venglustat tablets with standard therapy for adult patients with Fabry disease and left ventricular hypertrophy
AustriaStudy of bitopertin to improve sunlight tolerance in adults with erythropoietic protoporphyria or X-linked protoporphyria
BelgiumStudy of BLU-808 tablets compared to placebo in adults with chronic inducible urticaria and chronic spontaneous urticaria
DenmarkStudy of Tibulizumab to Treat Adults with Hidradenitis Suppurativa
GermanySafety Study of Switching from Current Treatment to Garadacimab in Patients Age 12 and Older with Hereditary Angioedema
GermanyStudy of ruxolitinib cream applied to the skin for people with hidradenitis suppurativa
BelgiumStudy of ruxolitinib cream for treating hidradenitis suppurativa in adult patients
BulgariaThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
